Quantcast
Last updated on April 19, 2014 at 7:50 EDT

Latest COLLERETTO GIACOSA Stories

2012-12-03 00:20:20

MILAN and COLLERETTO GIACOSA, Italy, December 3, 2012 /PRNewswire/ -- Mediolanum Farmaceutici SpA, a privately owned company that leads the Mediolanum Farmaceutici Group of companies, and Genovax srl, a private company which belongs to the portfolio of Eporgen Venture and was originated from the University of Genoa , announced the acquisition by Mediolanum of the global rights to GX301, Genovax's therapeutic vaccine to treat various types of cancer. The first clinical study with...